ACTIVE

CEFALY Technology

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

-6,3 M €

-138.7% YoY

Revenue

14,2 M €

+3.0% YoY

Equity

-14,4 M €

-77.6% YoY

Workforce

3,6 ETP

-5.3% YoY

What does CEFALY Technology do?

CEFALY Technology is a Private limited company incorporated in 2004. Its main activity is: Manufacture of irradiation, electromedical and electrotherapeutic equipment. Its registered office is in Liège. It employs on average 3,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0870.578.661

Incorporation

13/12/2004

Legal form

Private limited company

Registered office

Boulevard de Patience et Beaujonc 3
4000 Liège · WallonieSee on map

Contributed capital

7 333 269,71 €

Latest accounts

31/12/2024

Average workforce

3,6 ETP

Activities (NACE)

26600Manufacture of irradiation, electromedical and electrotherapeutic equipment· main 26600Manufacture of irradiation, electromedical and electrotherapeutic equipment 32500Manufacture of medical and dental instruments and supplies 32500Manufacture of medical and dental instruments and supplies 33101Repair of fabricated metal products, machinery and equipment

Joint committees (2)

Signals

Healthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	14,2 M €	+3.0%	13,8 M €	+27.3%	10,8 M €	-7.3%	11,7 M €		–		9,2 M €	+0.4%	9,1 M €	+35.1%	6,8 M €	+22.2%	5,5 M €	+1.4%	5,5 M €	+11.3%	4,9 M €		–		2,2 M €	+34.9%	1,6 M €	+66.6%	966,9 k €	+62.9%	593,5 k €	-42.4%	1 M €	+19.2%	863,8 k €	+92.6%	448,4 k €
EBITDA	-2,7 M €	-164%	-1 M €	+44.7%	-1,8 M €	+72.7%	-6,7 M €	-388%	-1,4 M €	-34.0%	-1 M €	-132%	3,2 M €	+107%	1,5 M €	-3.9%	1,6 M €	-0.3%	1,6 M €	-12.6%	1,8 M €	+143%	757,1 k €	+52.9%	495,2 k €	+74.0%	284,7 k €	+58.7%	179,3 k €	+281%	-98,8 k €	-151%	194,3 k €	+121%	88 k €	+134%	37,7 k €
Operating result	-3 M €	-59.2%	-1,9 M €	+37.9%	-3 M €	+63.2%	-8,3 M €	-244%	-2,4 M €	-16.6%	-2,1 M €	-195%	2,2 M €	+158%	840,2 k €	-19.3%	1 M €	-8.0%	1,1 M €	-19.1%	1,4 M €	+129%	609,3 k €	+67.4%	364 k €	+67.9%	216,7 k €	+147%	87,7 k €	+148%	-181,1 k €	-340%	75,4 k €	+58.9%	47,5 k €	+185%	16,6 k €
Net result	-6,3 M €	-139%	-2,6 M €	+32.2%	-3,9 M €	+56.3%	-8,9 M €	-213%	-2,8 M €	-21.1%	-2,3 M €	-199%	2,4 M €	+170%	872,5 k €	-30.6%	1,3 M €	-4.2%	1,3 M €	-0.4%	1,3 M €	+121%	594,9 k €	+73.0%	343,8 k €	+79.6%	191,5 k €	+287%	49,5 k €	+123%	-216 k €	-636%	40,3 k €	+21.7%	33,1 k €	+217%	10,5 k €
Balance sheet
Equity	-14,4 M €	-77.6%	-8,1 M €	-48.1%	-5,5 M €	-244%	-1,6 M €	-129%	5,5 M €	+61.0%	3,4 M €	-50.0%	6,8 M €	+49.0%	4,6 M €	+8.8%	4,2 M €	+19.3%	3,5 M €	+40.0%	2,5 M €	+71.5%	1,5 M €	+64.2%	896,8 k €	+78.8%	501,6 k €	+128%	219,8 k €	+476%	38,2 k €	-85.0%	254,2 k €	+18.8%	213,9 k €	+18.3%	180,8 k €
Total assets	6,9 M €	+1.7%	6,8 M €	+3.6%	6,6 M €	-25.7%	8,9 M €	-9.2%	9,8 M €	+51.0%	6,5 M €	-35.0%	9,9 M €	+15.1%	8,6 M €	+28.1%	6,7 M €	+26.9%	5,3 M €	+18.4%	4,5 M €	+72.7%	2,6 M €	+4.7%	2,5 M €	+72.3%	1,4 M €	+13.7%	1,3 M €	+44.1%	877,7 k €	-18.1%	1,1 M €	+62.0%	661,2 k €	+40.7%	470 k €
Cash	504,1 k €	+156%	196,6 k €	-73.0%	728 k €	-72.4%	2,6 M €	+453%	477,2 k €	-19.0%	589,4 k €	-80.8%	3,1 M €	-10.0%	3,4 M €	+10.8%	3,1 M €	+27.2%	2,4 M €	+18.4%	2 M €	+172%	749,9 k €	-1.7%	762,8 k €	+92.8%	395,7 k €	+15.6%	342,4 k €	+0.5%	340,8 k €	-13.0%	391,9 k €	+214%	125 k €	-25.4%	167,5 k €
Debts	21,1 M €	+48.4%	14,2 M €	+24.9%	11,4 M €	+15.1%	9,9 M €	+133%	4,3 M €	+39.8%	3 M €	-1.6%	3,1 M €	-23.5%	4 M €	+60.5%	2,5 M €	+55.3%	1,6 M €	-17.0%	2 M €	+74.3%	1,1 M €	-29.1%	1,6 M €	+68.9%	935,7 k €	-6.4%	1 M €	+19.1%	839,5 k €	+2.7%	817,3 k €	+82.7%	447,4 k €	+54.7%	289,2 k €
Other
Workforce	3,6 ETP	-5.3%	3,8 ETP	-28.3%	5,3 ETP	-5.4%	5,6 ETP	-49.5%	11,1 ETP	-32.3%	16,4 ETP	-6.8%	17,6 ETP	+6.0%	16,6 ETP	+28.7%	12,9 ETP	-2.3%	13,2 ETP	+45.1%	9,1 ETP	+56.9%	5,8 ETP	+3.6%	5,6 ETP	+7.7%	5,2 ETP	0.0%	5,2 ETP	+36.8%	3,8 ETP	+15.2%	3,3 ETP	+13.8%	2,9 ETP	+190%	1,0 ETP

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 6 ended

Active mandates

Andrew Page

Director · since 23 septembre 2025

Active

Gabriel W. Becher

Director · since 13 juin 2019

Active

Jennifer Trainor-McDermott

Director · since 13 juin 2019 · until 23 septembre 2025

Active

Michael Mitchnik

Director · since 13 juin 2019

Active

Ended mandates

GABRIEL BECHER

Director · since 13 juin 2019

Ended

Jennifer Trainor

Director · since 13 juin 2019

Ended

Jennifer Trainor-McDermott

Director · since 13 juin 2019

Ended

Mike MITCHNIK

Director · since 13 juin 2019

Ended

At this address

Other companies at this address

Company	CBE no.
Abscint● Active	0749.828.410
AMPACIMON● Active	0827.990.317
Amyl Therapeutics● Active	0758.775.372
BECARV● Bankrupt	0840.777.885
BE.SPINE● Active	1013.110.857
DERMAX● Active	0667.730.677
DIANOSIC● Active	1034.558.646
DW Cefaly Holding● Active	0725.837.241
EARTH ALIVE CLEAN TECHNOLOGIES BELGIUM● Active	1023.778.481
EXO Biologics● Active	0732.982.379
ExoXpert● Active	1003.807.666
Hirundo Biosciences● Active	0681.855.065
HolyFox Invest● Active	1010.693.181
Hyloris● Active	0669.738.676
Hyloris Developments● Active	0542.737.368
Hyloris Pharmaceuticals● Active	0674.494.151
Hyloris Therapeutics● Active	1025.029.385
LEGIAPARK● Active	0728.589.170
MAN & SCIENCE● Active	0837.403.770
ONCORADIOMICS● Active	0662.719.440

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Full model	Full model	Full model	Full model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/12/2025	05/05/2025	15/04/2025	28/01/2025	30/06/2023	14/08/2020
General meeting	27/11/2025	29/04/2025	10/04/2025	17/01/2025	31/05/2023	30/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2024	27/11/2025	03/12/2025	French	PDF
Full model	31/12/2023	29/04/2025	05/05/2025	French	PDF
Full model	31/12/2022	10/04/2025	15/04/2025	French	PDF
Full model	31/12/2021	17/01/2025	28/01/2025	French	PDF
Abridged model	31/12/2020	31/05/2023	30/06/2023	French	PDF
Abridged model	31/12/2019	30/06/2020	14/08/2020	French	PDF
Abridged model	31/12/2018	29/05/2019	20/06/2019	French	PDF
Abridged model	31/12/2017	05/07/2018	05/07/2018	French	PDF
Abridged modelCorrection	31/12/2016	16/06/2017	17/07/2017	French	PDF
Abridged model	31/12/2016	16/06/2017	16/06/2017	French	PDF
Abridged model	31/12/2015	22/06/2016	05/07/2016	French	PDF
Abridged modelCorrection	31/12/2014	19/06/2015	05/01/2016	French	PDF
Abridged model	31/12/2014	19/06/2015	09/07/2015	French	PDF
Abridged model	31/12/2013	27/08/2014	28/08/2014	French	PDF
Abridged model	31/12/2012	05/07/2013	12/07/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	07/06/2012	French	PDF
Abridged model	31/12/2010	12/05/2011	27/06/2011	French	PDF
Abridged model	31/12/2009	18/06/2010	30/07/2010	French	PDF
Abridged model	31/12/2008	17/06/2009	19/06/2009	French	PDF
Abridged model	31/12/2007	30/06/2008	04/07/2008	French	PDF
Abridged model	31/12/2006	08/06/2007	16/08/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 6 ended

Active mandates

Andrew Page

Director · since 23 septembre 2025

Active

Gabriel W. Becher

Director · since 13 juin 2019

Active

Jennifer Trainor-McDermott

Director · since 13 juin 2019 · until 23 septembre 2025

Active

Michael Mitchnik

Director · since 13 juin 2019

Active

Ended mandates

GABRIEL BECHER

Director · since 13 juin 2019

Ended

Jennifer Trainor

Director · since 13 juin 2019

Ended

Jennifer Trainor-McDermott

Director · since 13 juin 2019

Ended

Mike MITCHNIK

Director · since 13 juin 2019

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates07/08/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates18/11/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2024
DEMISSIONS, NOMINATIONS
PDF
Registered office26/09/2024
SIEGE SOCIAL
PDF
Capital / shares03/02/2021
CAPITAL, ACTIONS
PDF
Mandates09/06/2020
DEMISSIONS, NOMINATIONS
PDF
Capital / shares03/06/2020
CAPITAL, ACTIONS - ASSEMBLEE GENERALE - MODIFICATION FORME JURIDIQUE
PDF
Mandates16/07/2019
OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-6,3 M €↓
2023
Annual accounts 2023-2,6 M €↑
2022
Annual accounts 2022-3,9 M €↑
2021
Annual accounts 2021-8,9 M €↓
2020
Annual accounts 2020-2,8 M €↓
2019
Annual accounts 2019-2,3 M €↓
2018
Annual accounts 20182,4 M €↑
2017
Annual accounts 2017872,5 k €↓
2016
Annual accounts 20161,3 M €↓
2015
Annual accounts 20151,3 M €↓
2014
Annual accounts 20141,3 M €↑
2013
Annual accounts 2013594,9 k €↑
2012
Annual accounts 2012343,8 k €↑
2011
Annual accounts 2011191,5 k €↑
2010
Annual accounts 201049,5 k €↑
2009
Annual accounts 2009-216 k €↓
2008
Annual accounts 200840,3 k €↑
2007
Annual accounts 200733,1 k €↑
2006
Annual accounts 200610,5 k €
13/12/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CEFALY Technology

Overview

What does CEFALY Technology do?

Trend over 19 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline